Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Electrocardiographic (ECG) Ventricular Repolarization and Transthoracic Impedance Cardiography (ICG) Parameters in Patients with COVID-19 and After the Disease: Persistence and Prognostic Significance of These Changes

NCT06674278 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.

NCT NCT06674278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06674278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Electrocardiographic (ECG) Ventricular Repolarization and Transthoracic Impedance Cardiography (ICG) Parameters in Patients with COVID-19 and After the Disease: Persistence and Prognostic Significance of These Changes
Lead sponsor
Lithuanian University of Health Sciences
Phase
Observational
Overall status
Not yet recruiting
Start date
November 30, 2024
Completion date
January 31, 2027
Enrollment
215 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, impedance cradiography, post covid-19, ventricular repolarization